Split History
| Home |
| Free Dividend Report |
| Stock Splits Calendar |
| ATNM Stock Split History |
| Preferred Stock Newsletter |
| ATNM Options Chain |
| ATNM Message Board |
Actinium Pharmaceuticals (ATNM) has 1 split in our ATNM split history database. The split for ATNM took place on August 11, 2020. This was a 1 for 30 reverse split, meaning for each 30 shares of ATNM owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 33.3333333333333 share position following the split.
When a company such as Actinium Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the ATNM split history from start to finish, an original position size of 1000 shares would have turned into 33.3333333333333 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Actinium Pharmaceuticals shares, starting with a $10,000 purchase of ATNM, presented on a split-history-adjusted basis factoring in the complete ATNM split history.
|
Growth of $10,000.00 Without Dividends Reinvested |
||
| Start date: | 04/22/2014 | |
| End date: | 04/17/2024 | |
| Start price/share: | $377.70 | |
| End price/share: | $7.25 | |
| Dividends collected/share: | $0.00 | |
| Total return: | -98.08% | |
| Average Annual Total Return: | -32.67% | |
| Starting investment: | $10,000.00 | |
| Ending investment: | $191.88 | |
| Years: | 9.99 | |
 |
| About Actinium Pharmaceuticals |
| Actinium Pharmaceuticals is a clinical-stage biopharmaceutical company. Co.'s targeted radiotherapies combine the cell-killing ability of radiation via a radioisotope payload with a targeting agent to deliver radiation in a precise manner inside the body to specific targeted cells. Co.'s Iomab-B and Actimab-A product candidates are focused on addressing the medical needs in relapsed or refractory acute myeloid leukemia (AML) in a complementary manner and are directed at different parts of the patient journey. Iomab-B is a targeted radiotherapy consisting of apamistamab. Actimab-A (225Ac-lintuzumab satetraxetan) program is focused on developing combinations with other AML treatment regimens. According to our ATNM split history records, Actinium Pharmaceuticals has had 1 split. |
| ATNM Split History Table | |
| Date | Ratio |
| 08/11/2020 | 1 for 30 |
| Healthcare Stock Splits |
| ATNM is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:
ATNX Split History
|
Free ATNM Email Alerts:
ATNM Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.